How do I find recruiting Chronic Lymphocytic Leukemia clinical trials?

Corterve aggregates actively recruiting Chronic Lymphocytic Leukemia studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.

Are Chronic Lymphocytic Leukemia clinical trials free to join?

Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.

Who can take part in a Chronic Lymphocytic Leukemia clinical trial?

Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.

Chronic Lymphocytic Leukemia Clinical Trials

Chronic Lymphocytic Leukemia clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for chronic Lymphocytic Leukemia. Corterve aggregates actively recruiting Chronic Lymphocytic Leukemia studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.

Browse all Chronic Lymphocytic Leukemia trials Take the free assessment

Recruiting Chronic Lymphocytic Leukemia studies

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
NCT01087333National Cancer Institute (NCI)Bethesda, Maryland
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
NCT05645107PHASE3Grifols Therapeutics LLCHuntington Park, California
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
NCT06708897PHASE1Lomond Therapeutics Holdings, Inc.Louisville, Kentucky
Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
NCT06967610PHASE2M.D. Anderson Cancer CenterHouston, Texas
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872PHASE3BeOne MedicinesLaguna Hills, California
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
NCT04269902PHASE3National Cancer Institute (NCI)Birmingham, Alabama
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
NCT07061951PHASE2National Cancer Institute (NCI)Duarte, California
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
NCT07020533PHASE1City of Hope Medical CenterDuarte, California
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
NCT07424833PHASE1Ascentage Pharma Group Inc.Los Angeles, California
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
NCT05724121National Heart, Lung, and Blood Institute (NHLBI)Bethesda, Maryland
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
NCT07342478PHASE3Newave Pharmaceutical IncBethesda, Maryland
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
NCT00923507National Heart, Lung, and Blood Institute (NHLBI)Bethesda, Maryland

See all 110 recruiting Chronic Lymphocytic Leukemia trials →

Chronic Lymphocytic Leukemia trials by state

Chronic Lymphocytic Leukemia trials by metro

Frequently asked questions

How do I find recruiting Chronic Lymphocytic Leukemia clinical trials?: Corterve aggregates actively recruiting Chronic Lymphocytic Leukemia studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
Are Chronic Lymphocytic Leukemia clinical trials free to join?: Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
Who can take part in a Chronic Lymphocytic Leukemia clinical trial?: Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.